Scottish Widows Investment Partnership
Scottish Widows Investment Partnership (SWIP) is one of Europe&s;s largest asset management companies and part of the Lloyds Banking Group.
Business Model:
Revenue: $10.5M
Employees: 2-10
Rankings
Detailed Scottish Widows Investment Partnership Information
Scottish Widows Investment Partnership was acquired by
Aberdeen Asset Management.
The acquisition happend on 2013-11-18.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Edinburgh One, 60 Morrison Street
City: Edinburgh
State: scotland
Zip: EH3 8BE
Country: GB
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Scottish Widows Investment Partnership – SWIP – is one of the largest asset management companies in Europe. Their teams are recognised as high fliers within the industry. Their performance is based on their skills, backed by thorough research, and the ability to uncover and capitalise on opportunities as soon as they arise. They invest across all asset classes, including equities, property, bonds and cash. They also offer specialist expertise in multi-manager and multi-asset solutions. Their goal: to provide superior risk-adjusted returns and quality service for their clients, which include individuals, pension funds, charities and financial institutions from around the world. Whatever your investment requirements, their teams have the innovation, drive and skill to deliver investment solutions that perform.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2010 | Cara Therapeutics | Series D | 0 |
| 4/2007 | Radius Health | Series B | 57.5M |
| 12/2011 | Radius Health | Private Equity Round | 21.4M |
| 11/2006 | Cara Therapeutics | Series C | 24M |
| 7/2011 | Radius Health | Series C | 66M |
| 11/2008 | Radius Health | Series C | 15M |
| 8/2019 | The PRS REIT | Post-IPO Debt | 0 |
| 6/2007 | 7TM Pharma | Series D | 22M |
| 6/2004 | ARYx Therapeutics | Series D | 55M |
| 8/2019 | The PRS REIT | Post-IPO Debt | 0 |
| 12/2011 | Radius Health | Private Equity Round | 0 |
| 7/2011 | Radius Health | Series C | 0 |
| 7/2010 | Cara Therapeutics | Series D | 0 |
| 11/2008 | Radius Health | Series C | 0 |
| 6/2007 | 7TM Pharma | Series D | 0 |
| 4/2007 | Radius Health | Series B | 0 |
| 11/2006 | Cara Therapeutics | Series C | 0 |
| 6/2004 | ARYx Therapeutics | Series D | 0 |
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
